propidium has been researched along with bay 11-7082 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, RL; Chen, S; Conney, AH; Hansson, A; Huberman, E; Marín, YE; Rabson, AB; Suh, J; Zheng, X | 1 |
| Anke, T; Erkel, G; Wisser, G | 1 |
2 other study(ies) available for propidium and bay 11-7082
| Article | Year |
|---|---|
Enhancement of TPA-induced growth inhibition and apoptosis in myeloid leukemia cells by BAY 11-7082, an NF-kappaB inhibitor.
Topics: Active Transport, Cell Nucleus; Apoptosis; Cell Adhesion; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; DNA; DNA Damage; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; I-kappa B Proteins; Immunophenotyping; Leukemia, Myeloid; NF-kappa B; NF-KappaB Inhibitor alpha; Nitriles; Phosphorylation; Propidium; Protein Kinase C; Protein Kinase C beta; Sulfones; Tetradecanoylphorbol Acetate; Time Factors | 2005 |
Influence of the fungal NF-kappaB inhibitor panepoxydone on inflammatory gene expression in MonoMac6 cells.
Topics: Apoptosis; Autoimmune Diseases; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Survival; Electrophoretic Mobility Shift Assay; Fluorescein-5-isothiocyanate; Gene Expression; Genes, Reporter; Humans; Inflammation; Lipopolysaccharides; NF-kappa B; Nitriles; Oligonucleotide Array Sequence Analysis; Propidium; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfones; Tetradecanoylphorbol Acetate | 2007 |